Frequently Asked Questions
Lumateperone or Caplyta is a drug that is used to manage schizophrenia as well as treat other neuropsychiatric conditions. It is a medicine that belongs to the second generation of atypical antipsychotics and demonstrates a unique mode of action.
Caplyta prescribed in the treatment of following ailments:
- Caplyta is a medication that can be used to treat schizophrenia, which is a mental disorder that can produce disturbed or abnormal thinking, a loss of enthusiasm in life, and intense or inappropriate emotions.
- The drug known as atypical antipsychotics includes lumateperone as one of its members.
- It achieves its effects by altering the action of a number of naturally occurring chemicals already present in the brain.
There is a possibility that Caplyta will result in adverse effects. Talk to your primary care provider if any of the following symptoms become very bothersome or if they fail to improve.
Some less serious side effects include:
- Excessive weariness or a state of fatigue
- Weight increase
- Dry mouth
- Cerebrovascular Adverse Reactions in Elderly Patients Struggling with Dementia
- Other Related Forms of Psychosis: An increase in the incidence of cerebrovascular adverse events.
- Neuroleptic Malignant Syndrome: Control the situation by immediately stopping Caplyta.
- When treating tardive dyskinesia, it is recommended that treatment be stopped if it is deemed clinically appropriate.
- Transformations of the Metabolic System: Be on the lookout for symptoms of hyperglycemia and diabetes mellitus, as well as dyslipidemia and weight gain.
- Perform a complete blood count (CBC) on individuals who have a pre-existing low white blood cell count (WBC), or who have a history of leukopenia or neutropenia.